These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25023913)

  • 21. Regional variation in spending and survival for older adults with advanced cancer.
    Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
    J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
    Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
    J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
    Krumholz HM; Nuti SV; Downing NS; Normand SL; Wang Y
    JAMA; 2015 Jul; 314(4):355-65. PubMed ID: 26219053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
    Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
    Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare Outpatient Physical Therapy Expenditures Vary by Diagnosis and Functional Mobility.
    Pardasaney PK; Pope GC; Amico P; Deutsch A; Kline T; Dever J; Silver B; Scheffler S; Meadow A; West P
    Phys Ther; 2019 May; 99(5):526-539. PubMed ID: 30801639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refinements of the Medicare Outpatient Therapy Annual Expenditure Limit Policy.
    Amico P; Pope GC; Pardasaney P; Silver B; Dever JA; Meadow A; West P
    Phys Ther; 2015 Dec; 95(12):1638-49. PubMed ID: 26089039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic burden of prostate cancer survivorship care.
    Skolarus TA; Zhang Y; Miller DC; Wei JT; Hollenbeck BK
    J Urol; 2010 Aug; 184(2):532-8. PubMed ID: 20620413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational Variation in End-of-Life Care Intensity.
    Hyder JA; Haring RS; Sturgeon D; Gazarian PK; Jiang W; Cooper Z; Lipsitz SR; Prigerson HG; Weissman JS
    Am J Hosp Palliat Care; 2018 Mar; 35(3):377-383. PubMed ID: 28571496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer.
    Alwhaibi M; Sambamoorthi U; Madhavan S; Walkup JT
    Psychooncology; 2017 Dec; 26(12):2215-2223. PubMed ID: 27891701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Costs of Fall-Related Injuries among Older Adults: Annual Per-Faller, Service Component, and Patient Out-of-Pocket Costs.
    Hoffman GJ; Hays RD; Shapiro MF; Wallace SP; Ettner SL
    Health Serv Res; 2017 Oct; 52(5):1794-1816. PubMed ID: 27581952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent and sources of geographic variation in Medicare end-stage renal disease expenditures.
    Hirth RA; Tedeschi PJ; Wheeler JR
    Am J Kidney Dis; 2001 Oct; 38(4):824-31. PubMed ID: 11576886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
    Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
    Hung P; Hsu SH; Wang SY
    Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer.
    Paravati AJ; Boero IJ; Triplett DP; Hwang L; Matsuno RK; Xu B; Mell LK; Murphy JD
    J Oncol Pract; 2015 Sep; 11(5):403-9. PubMed ID: 26265172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in Hospital Episode Costs With Bariatric Surgery.
    Grenda TR; Pradarelli JC; Thumma JR; Dimick JB
    JAMA Surg; 2015 Dec; 150(12):1109-15. PubMed ID: 26376433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of Medicare expenditures in the medical expenditure panel survey.
    Zuvekas SH; Olin GL
    Inquiry; 2009; 46(1):92-108. PubMed ID: 19489486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk adjustment for Medicare beneficiaries with Alzheimer's disease and related dementias.
    Lin PJ; Maciejewski ML; Paul JE; Biddle AK
    Am J Manag Care; 2010 Mar; 16(3):191-8. PubMed ID: 20225914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in treatment costs for localized prostate cancer: the healthy screenee effect.
    Zeliadt SB; Etzioni R; Ramsey SD; Penson DF; Potosky AL
    Med Care; 2007 Feb; 45(2):154-9. PubMed ID: 17224778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.
    Chen C; Petterson S; Phillips R; Bazemore A; Mullan F
    JAMA; 2014 Dec; 312(22):2385-93. PubMed ID: 25490329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.